USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
METABOLIC SOLUTIONS DEVELOPMENT CO
Address:
161 E. Michigan Ave, 4th Floor
KALAMAZOO, MI 49007-3926
Phone:
N/A
URL:
N/A
EIN:
120409983
DUNS:
801994281
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $121,956.00 1
STTR Phase I $280,775.00 2
STTR Phase II $2,378,645.00 2

Award List:

PPAR-sparing/free Thiazolidinediones for Treatment of Diabetes

Award Year / Program / Phase:
2010 / STTR / Phase II
Award Amount:
$1,242,623.00
Agency:
HHS
Principal Investigator:
Rolf F. Kletzien – 304-293-2494
Research Institution:
University Of California San Diego
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The overall objective of our proposed research is to discover a PPARg-free thiazolidinedione (TZD) which shows antidiabetic activity in a rodent model of Type 2 diabetes and demonstrates the necessary drug-like qualities to become a clinical candidate for human… More

Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease

Award Year / Program / Phase:
2011 / STTR / Phase II
Award Amount:
$1,136,022.00
Agency:
HHS
Principal Investigator:
Rolf F. Kletzien – 304-293-2494
Research Institution:
WASHINGTON UNIVERSITY
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in the United States. This condition encompasses both hepatic steatosis and the more severe non-alcoholic steatohepatitis. It is now estimated that 14-24% of the general population and… More

Therapeutic Use of mTOT Modulators in Polycystic Kidney Disease

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$121,956.00
Agency:
HHS
Principal Investigator:
Rolf F. Kletzien – 269-491-5690
Abstract:
? DESCRIPTION (provided by applicant): Polycystic kidney disease (PKD) is a term applied to a group of inherited disorders characterized by the presence of cysts in the kidney although multiple organs are typically affected. Renal pathologies found inessentially all forms of PKD include… More